PA
ICPT
Pinnacle Associates’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-197,237
| Closed | -$3.66M | – | 850 |
|
|
2023
Q3 | $3.66M | Sell |
197,237
-2,882
| -1% | -$53.4K | 0.07% | 256 |
|
|
2023
Q2 | $2.21M | Sell |
200,119
-8,680
| -4% | -$96K | 0.04% | 346 |
|
|
2023
Q1 | $2.8M | Buy |
208,799
+1,526
| +0.7% | +$20.5K | 0.06% | 266 |
|
|
2022
Q4 | $2.56M | Sell |
207,273
-5,275
| -2% | -$65.3K | 0.06% | 267 |
|
|
2022
Q3 | $2.97M | Buy |
212,548
+98,778
| +87% | +$1.38M | 0.07% | 247 |
|
|
2022
Q2 | $1.57M | Sell |
113,770
-724
| -0.6% | -$10K | 0.03% | 335 |
|
|
2022
Q1 | $1.86M | Sell |
114,494
-4,110
| -3% | -$66.9K | 0.03% | 354 |
|
|
2021
Q4 | $1.93M | Sell |
118,604
-2,201
| -2% | -$35.9K | 0.03% | 356 |
|
|
2021
Q3 | $1.79M | Sell |
120,805
-2,155
| -2% | -$32K | 0.03% | 356 |
|
|
2021
Q2 | $2.46M | Buy |
122,960
+2,742
| +2% | +$54.8K | 0.04% | 306 |
|
|
2021
Q1 | $2.78M | Sell |
120,218
-13,610
| -10% | -$314K | 0.05% | 282 |
|
|
2020
Q4 | $3.31M | Sell |
133,828
-8,784
| -6% | -$217K | 0.07% | 244 |
|
|
2020
Q3 | $5.91M | Sell |
142,612
-5,220
| -4% | -$216K | 0.14% | 163 |
|
|
2020
Q2 | $7.08M | Sell |
147,832
-2,580
| -2% | -$124K | 0.17% | 140 |
|
|
2020
Q1 | $9.47M | Sell |
150,412
-23,881
| -14% | -$1.5M | 0.29% | 99 |
|
|
2019
Q4 | $21.6M | Sell |
174,293
-16,895
| -9% | -$2.09M | 0.47% | 61 |
|
|
2019
Q3 | $12.7M | Buy |
191,188
+61,373
| +47% | +$4.07M | 0.3% | 90 |
|
|
2019
Q2 | $10.3M | Sell |
129,815
-12,373
| -9% | -$984K | 0.24% | 118 |
|
|
2019
Q1 | $15.9M | Sell |
142,188
-4,080
| -3% | -$456K | 0.36% | 80 |
|
|
2018
Q4 | $14.7M | Sell |
146,268
-7,090
| -5% | -$715K | 0.38% | 72 |
|
|
2018
Q3 | $19.4M | Sell |
153,358
-24,277
| -14% | -$3.07M | 0.4% | 68 |
|
|
2018
Q2 | $14.9M | Sell |
177,635
-28,795
| -14% | -$2.42M | 0.31% | 92 |
|
|
2018
Q1 | $12.7M | Sell |
206,430
-8,860
| -4% | -$545K | 0.25% | 109 |
|
|
2017
Q4 | $12.6M | Buy |
+215,290
| New | +$12.6M | 0.24% | 106 |
|